Skip to main content
Fig. 8 | BMC Cancer

Fig. 8

From: Combined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer

Fig. 8

Survival curves according to the pre- and postoperative LCR values of patients with stage II/III gastric cancer who were ineligible for adjuvant chemotherapy, particularly those with pT1N2-3b and pT3N0. The overall (a) and relapse-free (b) 5-year survival rates were significantly worse in those with pre-LCRL°w and post-LCRL°w than in other patients (p = 0.031 and p = 0.043, respectively)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us